Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Nature Medicine 13, 266 (1 March 2007) | doi:10.1038/nm0307-266;
After decades of drought, new drug possibilities flood TB pipeline
Abstract
For the first time in decades, there are nearly 30 drugs for tuberculosis (TB) under development. Most are still in preclinical testing—the earliest one might hit the clinic is 2010—but less than just five years ago, the pipeline was running empty.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
